Thomas Nusbickel - May 13, 2021 Form 4 Insider Report for CorMedix Inc. (CRMD)

Role
EVP, Chief Commercial Officer
Signature
/s/ Thomas Nusbickel
Stock symbol
CRMD
Transactions as of
May 13, 2021
Transactions value $
$0
Form type
4
Date filed
5/20/2021, 04:18 PM
Next filing
Feb 23, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +260K $0.00 260K May 13, 2021 Common Stock 260K $7.56 Direct F1
transaction CRMD Stock Option (Right to Buy Common Stock) Award $0 +7.5K $0.00 7.5K May 13, 2021 Common Stock 7.5K $7.56 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows: 160,000 will vest over four years in four (4) equal installments on the first four anniversaries of May 13, 2021. The remaining 100,000 options vest on the achievement of certain milestones, subject to continued employment.
F2 These options were granted on May 13, 2021. These options shall vest in full on the first anniversary of the grant date, subject to continued employment.